Jason Bock, Ph.D.
Co-Founder & Chief Executive Officer, CTMC
Jason has 20+ years of innovative biologics development and commercialization experience. He is currently CEO of CTMC - a joint venture between Resilience + MD Anderson Cancer Center. Based in Houston, TX, CTMC+ was conceived to accelerate patient access to impactful cell therapies by bridging cell therapy development and manufacturing with MD Anderson’s clinical trial capabilities. He previously held leadership positions at MD Anderson, Teva Pharmaceuticals, CoGenesys, and Human Genome Sciences.